PROK
ProKidney Corp.
1.60$
+1.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | – | 640.8% | |
| – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | 167,984.2% | 12,779.7% | |
| – | – | – | – | – | 73,794.7% | 5,798.1% | |
| – | – | – | – | – | 241,778.9% | 18,577.8% | |
| – | – | – | – | – | -241,678.9% | -18,477.8% | |
| – | – | – | – | – | 11.8% | 0.4% | |
| – | – | – | – | – | -215,701.3% | -16,931.5% | |
| – | – | – | – | – | -786.8% | 46.4% | |
| – | – | – | – | – | -80,507.9% | -7,725.2% | |
| – | – | – | – | – | -208,542.1% | -16,194.7% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.